U.S. readies plan to vaccinate kids ages 5-11 against COVID-19 | Inquirer News

U.S. readies plan to vaccinate kids ages 5-11 against COVID-19

/ 06:44 AM October 21, 2021

A syringe is filled with a dose of Pfizer's COVID-19 vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021.

  (REUTERS/File Photo)

WASHINGTON  – The Biden administration on Wednesday outlined its plan to vaccinate millions of U.S. children ages 5 to 11 as soon as the COVID-19 shot is authorized for them, readying doses and preparing locations ahead of the busy holiday season.

Unlike the mass vaccination centers used in the initial COVID-19 vaccine rollout, the White House said it is working to set up clinics in more than 100 children’s hospital systems nationwide as well as doctor’s offices, pharmacies and potentially schools.

Article continues after this advertisement

If Pfizer Inc and BioNTech SE’s vaccine wins wider authorization from the U.S. Food and Drug Administration, the plan aims to ensure quick and equitable distribution, the White House said.

FEATURED STORIES

FDA officials are reviewing the Pfizer/BioNTech application seeking authorization of its 2-dose vaccine for younger children, with its panel of outside advisers scheduled to weigh in on Oct. 26. The FDA typically follows the advice of its panel but is not required to do so.

Advisers to the U.S. Centers for Disease Control and Prevention (CDC) will weigh in on recommendations for the vaccine at a meeting on Nov. 2 and Nov. 3, helping to inform a final decision by its director.

Article continues after this advertisement

“Should the FDA and CDC authorize the vaccine, we will be ready to get shots in arms,” White House COVID response coordinator Jeff Zients told reporters, adding that the government had 15 million doses set to ship nationwide, with millions more going out in the weeks to follow.

Article continues after this advertisement

Once authorized, roughly 28 million more children in the United States would be eligible to receive what would be the first U.S. COVID-19 vaccine for younger kids. The Pfizer/BioNTech shot is already available to those ages 12-17, and the companies are still studying it for children younger than 5.

Article continues after this advertisement

Zients said the administration had worked with Pfizer to modify the packaging of the pediatric doses to make it easier to administer to children, including providing smaller needles.

While children have a lower rate of death from COVID-19, many face illness and long-term symptoms that are still being studied. Many adults who have been hesitant or opposed to the COVID-19 vaccine, and even some who did not oppose the vaccine for themselves, are expected to resist giving the shot to their children.

Article continues after this advertisement

CDC Director Dr. Rochelle Walensky told reporters that the agency would continue to recommend mask wearing in schools even as the vaccine is rolled out for children.

Walensky said the seven-day average of COVID-19 cases in the United States was down about 16% to some 75,500 cases per day. The seven-day average for hospitalizations was down about 11% to around 6,000 per day, and that the seven-day average for daily deaths was down about 3% to 1,200.

gsg
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Children, COVID-19, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.